Effects of cumin (Cuminum cyminum L.) essential oil supplementation on metabolic syndrome components: A randomized, triple‐blind, placebo‐controlled clinical trial
- 2 September 2019
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 33 (12) , 3261-3269
Abstract
Prevalence of metabolic syndrome (MetS), as a major health problem, is increasing. Very limited data exist on the effect of Cuminum cyminum L. essential oil (CuEO) on MetS components. Accordingly, this study aimed to examine the effect of CuEO supplementation on anthropometric indices, glycemic control, blood pressure, lipid profile, and insulin resistance in patients with MetS. In a randomized, triple‐blind, placebo‐controlled clinical trial, 56 patients with MetS aged 18–60 years received either 75 mg CuEO or placebo soft gel thrice daily for 8 weeks. Anthropometric indices and biochemical measurements were assessed at baseline and end of the study. At the end of study, except for diastolic blood pressure (DBP), the other assessed variables were not significantly different between two groups. In intra group analysis, placebo and CuEO groups both had nonsignificant decrements in DBP (mean difference [MD] with 95% CI: −3.31 [−7.11, 0.47] and −1.77 [−5.95, 2.40] mmHg, respectively). However, DBP was significantly lower in CuEO compared with the placebo group at the end of study (81.41 ± 5.88 vs. 84.09 ± 5.54 mmHg, MD with 95% CI: −3.98 [−7.60, −0.35] mmHg, p < .05). The results indicated that CuEO does not have any effect on MetS components, except for DBP in patients with MetS.Keywords
Funding Information
- Tabriz University of Medical Sciences (5/D/10479, 2017/5/8)
This publication has 32 references indexed in Scilit:
- Functional protein from cumin seed (Cuminum cyminum): Optimization and characterization studiesFood Hydrocolloids, 2014
- Mediterranean Diet for Primary Prevention of Cardiovascular DiseaseNew England Journal of Medicine, 2013
- Insulinotropic and β-cell protective action of cuminaldehyde, cuminol and an inhibitor isolated from Cuminum cyminum in streptozotocin-induced diabetic ratsBritish Journal of Nutrition, 2013
- Cuminum cyminum, a Dietary Spice, Attenuates Hypertension via Endothelial Nitric Oxide Synthase and NO Pathway in Renovascular Hypertensive RatsClinical and Experimental Hypertension, 2013
- Antidiabetic and antidyslipidemic activities of Cuminum cyminum L. in validated animal modelsMedicinal Chemistry Research, 2010
- A Comparative Study on Chemical Composition and Antioxidant Activity of Ginger (Zingiber officinale) and Cumin (Cuminum cyminum)Journal of Agricultural and Food Chemistry, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle EastDiabetes Care, 2009
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Cuminaldehyde: Aldose Reductase and α-Glucosidase Inhibitor Derived from Cuminum cyminum L. SeedsJournal of Agricultural and Food Chemistry, 2005